BCL2 and metabolic dysfunction-associated steatotic liver disease: The acridone derivative A22 selectively binds and stabilizes the i-motif structure, a BCL-2 gene promoter, upregulating BCL-2 expression and reducing hepatocyte apoptosis in NAFLD/NASH models.